ConductScience.org, home

Paper22697293

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.

Fraunholz I and 6 others. Radiat Oncol, 2012. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy. Papers, record 22697293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22697293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.
PubMed
Journal
Radiat Oncol
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.36
iCite
Revised in PubMed
2021-10-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fraunholz IIngeborg
2Rödel CClaus
3Distel LLuitpold
4Rave-Fränk MMarget
5Kohler DDaniela
6Falk SStefan
7Rödel FFranz

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anus NeoplasmsMajor topic
ChemoradiotherapyMajor topic
Inhibitor of Apoptosis ProteinsMajor topic
Antineoplastic Agents
Female
Fluorouracil
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Male
Middle Aged
Mitomycin
Neoplasm Staging
Risk Factors
Survivin

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120129247IAP regulation of metastasis.Cancer Cell2010https://conductscience.org/library/papers/20129247PubMed
215930309Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.Cancer Res2005https://conductscience.org/library/papers/15930309PubMed
312654446Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor.Int J Radiat Oncol Biol Phys2003https://conductscience.org/library/papers/12654446PubMed
411277325Immunohistochemical assessment of Ki-67 as prognostic cellular proliferation marker in anal canal carcinoma.J Exp Clin Cancer Res2000https://conductscience.org/library/papers/11277325PubMed
515326475Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms.Oncogene2004https://conductscience.org/library/papers/15326475PubMed
619259318Prognostic factors for squamous cell cancer of the anal canal.Gastrointest Cancer Res2008https://conductscience.org/library/papers/19259318PubMed
714695153Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.Clin Cancer Res2003https://conductscience.org/library/papers/14695153PubMed
89579842Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy.Br J Cancer1998https://conductscience.org/library/papers/9579842PubMed
916740757Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma.Clin Cancer Res2006https://conductscience.org/library/papers/16740757PubMed
1021041181Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study.Clin Cancer Res2010https://conductscience.org/library/papers/21041181PubMed
1121110807The role of survivin for radiation oncology: moving beyond apoptosis inhibition.Curr Med Chem2011https://conductscience.org/library/papers/21110807PubMed
1221118954Failure of downregulation of survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival.Clin Cancer Res2011https://conductscience.org/library/papers/21118954PubMed
1320704571Survivin and IAP proteins in cell-death mechanisms.Biochem J2010https://conductscience.org/library/papers/20704571PubMed
1418698017Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.Clin Cancer Res2008https://conductscience.org/library/papers/18698017PubMed
1521376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
1619559538Survivin: a new target for anti-cancer therapy.Cancer Treat Rev2009https://conductscience.org/library/papers/19559538PubMed
1721264751Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer.Surg Today2011https://conductscience.org/library/papers/21264751PubMed
1819399614Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.Dig Dis Sci2010https://conductscience.org/library/papers/19399614PubMed
1916919715Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy.Gynecol Oncol2007https://conductscience.org/library/papers/16919715PubMed
2019231102Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy.Int J Radiat Oncol Biol Phys2009https://conductscience.org/library/papers/19231102PubMed

See all 39 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
39024554Transcriptome and microbiome-immune changes across preinvasive and invasive anal cancer lesions.JCI Insight2024https://conductscience.org/library/papers/39024554PubMed
29268708Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.BMC Cancer2017https://conductscience.org/library/papers/29268708PubMed
29085358Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer.Front Immunol2017https://conductscience.org/library/papers/29085358PubMed
26845086Sequestering survivin to functionalized nanoparticles: a strategy to enhance apoptosis in cancer cells.Biomater Sci2016https://conductscience.org/library/papers/26845086PubMed
23494669Expression of survivin and its four splice variants in colorectal cancer and its clinical significances.Med Oncol2013https://conductscience.org/library/papers/23494669PubMed
23371446Anal cancer: are we making progress?Curr Oncol Rep2013https://conductscience.org/library/papers/23371446PubMed
23182495
An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma.
Mol Oncol2013https://conductscience.org/library/papers/23182495PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22697293

GET https://conductscience.org/api/papers/v1/22697293/references?page=2